XBiotech Inc. (XBIT)

7.87 -0.34 (-4.14%) 收市：04:00PM EDT

XBiotech Inc.

5217 Winnebago Lane
Austin, TX 78744
United States
512 386 2900
https://www.xbiotech.com

版塊: Healthcare
行業: Biotechnology
全職員工: 82

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. John Simard	Founder, President, CEO & Chairman	5.56M	無	1962
Ms. Angela Hu	Director of Finance, Principal Financial & Accounting Officer and Financial Controller	198.13k	無	1984
Dr. Sushma Shivaswamy Ph.D.	Chief Scientific Officer	449.99k	無	1978

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

公司管治

截至 2024年4月1日 止，XBiotech Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中：9；董事會：7；股東權利：5；現金賠償：9。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。